Michael Klichinsky
-
Carisma Therapeutics Selects First Drug Candidate Under Moderna Partnership, Triggers $2M Payment
Philadelphia-based Carisma Therapeutics has chosen an experimental cell therapy that targets the most prevalent type of liver cancer as the first drug development candidate under…
Founding Partners
Advertisement
Affiliate Partners
